Access to Healthcare
Key strategies for ensuring pipelines with improved access to healthcare
HK inno.N prioritizes the development of new drugs for meeting the unmet needs of patients, while contributing to a stable supply of medicines by producing generics and incrementally modified drugs for patients who cannot afford the original medicines. In addition, the Company continues to develop and manufacture drugs subjects to the Drug Shortage Prevention Program (smallpox vaccine, crystalloid fluids, etc.), which are often disregarded by other pharmaceutical companies due to economic reasons, and such efforts of the Company contribute to reducing disruption in patient care.
Activities to promote access to healthcare
High-quality pharmaceutical products breaking into the global market
HK inno.N strives to make the high-quality medicines of the Company reach more patients by entering the global market as well as taking the lead in the domestic market. Currently, K-CAB (Tablet) is supplied to local partners in developing countries such as Mexico and Indonesia by means of exporting the drug product, and the supply continues to extend to many GERD patients who have had difficulty accessing P-CAB products. In addition to K-CAB, other various prescription drugs of HK inno.N such as biologics, antibiotics, and TPN are supplied to about 20 countries in emerging markets and developing countries with excellent quality and reasonable prices.
Education/training for local health care professionals and employees in Korea
HK inno.N introduces its products through a variety of channels such as overseas pharmaceutical exhibitions, export consultation meetings and international partnerships, etc., and contributes to helping people from many different countries and walks of life enjoy advanced healthcare benefits and reduce the burden from the pain of diseases. With 'K-CAB' playing the role of a bridge to create opportunities, medical professionals from Korean gastroenterology-related societies and the local health professionals from relevant societies signed MOUs for education on gastrointestinal diseases and mutual exchanges, and in the case of the Philippines, where Biologics Epokine Prefilled Inj. (Erythropoietine) are supplied, local health professionals are invited to Korea every year for training to help patients in the Philippines undergoing kidney dialysis receive more effective treatment.
<Academic presentation on 'K-CAB' in gastroenterology-related societies>
For employees at the business sites in Korea, an in-house campaign is launched to raise awareness about specific diseases. On March 14, 2024, in celebration of World Kidney Day, a bouquet of cards were made to raise awareness about kidney disease and the cards were distributed to employees and healthcare professionals to raise awareness of kidney-related diseases.
Donating medicines
Going beyond the development and sale of medicines, HK inno.N delivers medicines through donations to vulnerable population who have difficulty purchasing medicines. In particular, the Company supplies medicines to patients through partnerships with NGOs and other organizations. In 2023, KRW 100 million worth of medicines were donated to a mobile clinic project for vulnerable people in medically underserved regions in Cambodia through People for Medical Cooperation International, and KRW 140 million worth of medicines were supplied for local residents affected by the prolonged war in Ukraine through the Korea Biotechnology Industry Organization.